News

HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced an agreement with Korean biotech Quratis Inc. to co-develop HDT’s revolutionary COVID-19…
Read More...

Gritstone bio, Inc. a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, announced that the company entered into a funding…
Read More...

Nexus Pharmaceuticals, Inc., a U.S.-based healthcare company and domestic pharmaceutical manufacturer, has received a patent covering applications of EMERPHED Ready-To-Use Ephedrine…
Read More...

Aurinia Pharmaceuticals Inc. announced the addition of two novel assets that will expand the Company’s rare autoimmune and kidney-related disease pipeline. “Over the past year, in…
Read More...

Virpax Pharmaceuticals, Inc. a company specializing in developing product candidates for pain management, CNS and anti-viral indications, today announced that it has received a written…
Read More...

Marrone Bio Innovations, Inc. an international leader in sustainable bioprotection and plant health solutions to support global agricultural needs, and Terramera, a global agtech leader…
Read More...

Exelixis, Inc. and Invenra, Inc. announced that they have expanded their discovery and licensing collaboration to include an additional 20 oncology targets. The augmented partnership…
Read More...

InnoCare, a leading biopharmaceutical company focusing on drug innovation for cancer and autoimmune diseases, announced the first subject dosed in clinical trial of novel TYK2 (Tyrosine…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced the publication of new data on the durability of the Moderna COVID-19 vaccine…
Read More...

Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, announced the extension of its collaboration with…
Read More...

Artiva Biotherapeutics, Inc. (“Artiva”), an oncology company focused on developing and commercializing primary allogeneic natural killer (NK) cell therapies to treat cancer, announced…
Read More...

ProBioGen is pleased to announce that Nobelpharma has signed a license agreement for the use of the AGE1.CR.pIX vaccine production platform to develop their lead vaccine. The signing of…
Read More...

Sheba Medical Center at Tel Hashomer, the largest hospital in the Middle East region, and Lonza, a leading global cell and gene therapy manufacturer, announced today that they have…
Read More...

Precision NanoSystems (PNI), a global leader in innovative solutions for genetic medicine development, will expand its global headquarters with a 75,000-square-foot facility currently…
Read More...

GentiBio, Inc., a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology,  announced it has closed on a Series A financing generating…
Read More...

C4 Therapeutics, Inc. (C4T) a clinical-stage biopharmaceutical company pioneering a new class of small-molecule medicines that selectively destroy disease-causing proteins through…
Read More...

Vensica Therapeutics ("Vensica"), a clinical stage biopharmaceutical company, announced that it has signed a strategic collaboration agreement with Merz Therapeutics, a business of the…
Read More...

Evotec SE announced the opening of the company’s late-stage clinical and commercial biologics cGMP manufacturing facility (J.POD 1 US) in Redmond, Washington. The innovative cGMP…
Read More...

Ceapro Inc. a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced that it has…
Read More...

I-Mab a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced positive interim data from its U.S. phase…
Read More...